This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsVersarien（9RV）株式概要バーサリエン社は、イギリス、ヨーロッパ、北米、そして国際的に、様々な産業分野にエンジニアリング・ソリューションを提供している。 詳細9RV ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析マイナスの株主資本 過去5年間で収益は年間3.7%減少しました。 過去1年間で株主の希薄化は大幅に進んだ 株式の流動性は非常に低い +3 さらなるリスクすべてのリスクチェックを見る9RV Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.0005455.6% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-12m9m2016201920222025202620282031Revenue UK£381.6kEarnings UK£35.9kAdvancedSet Fair ValueView all narrativesVersarien plc 競合他社Bio-GateSymbol: DB:BIG1Market cap: €6.8mBRAIN BiotechSymbol: XTRA:BNNMarket cap: €65.8mNabaltecSymbol: XTRA:NTGMarket cap: €94.2mH&R GmbH KGaASymbol: XTRA:2HRAMarket cap: €169.7m価格と性能株価の高値、安値、推移の概要Versarien過去の株価現在の株価UK£0.000552週高値UK£0.00152週安値UK£0.0005ベータ1.121ヶ月の変化0%3ヶ月変化0%1年変化0%3年間の変化-99.39%5年間の変化-99.90%IPOからの変化-99.90%最新ニュースお知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct Listingお知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdomお知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct Listingお知らせ • Dec 10Versarien plc Announces the Launch of New BiosensorsVersarien Plc announced the launch of a new biosensor chip utilising novel graphene barristor sensor platform technology. These graphene barristor devices, developed in South Korea by A Barristor Company ("ABC"), will utilise chemical vapour deposition ("CVD") grown graphene, that is produced under a Versarien licence. Versarien has signed a distribution agreement with ABC to distribute the products in the UK and Europe. A barristor (triode device) is a new type of graphene-based transistor with a Schottky barrier between graphene and silicon. The current modulation is amplified more than 10,000 times compared to graphene field-effect transistors ("GFET") enabling the barristor transistors to overcome many GFET limitations. In these new products, the graphene surface is terminated with either pyrenebutanoic acid succinimidyl ester ("PBASE") or a customer preferred linker. PBASE is one of the most frequently used linkers for the surface modification of field-effect transistor (FET) biosensors based on carbon nanotubes and graphene. The products can be supplied as individual chips or on a wafer scale. It is expected that the CVD graphene used in the products will be supplied by MCK Tech Co. Ltd. ("MCK Tech") in South Korea, which is an existing Licensing partner of Versarien, and it will also undertake some of the device fabrication. The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC's product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.お知らせ • Sep 30Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million.Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million on September 30, 2024. The consideration of £0.55 million is payable in cash, in 16 equal quarterly instalments of £0.0034 million, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £0.146 million and had net assets at 30 September 2023 of £0.411 million. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes. Matthew Johnson, Adam Cowl of SP Angel Corporate Finance LLP acted as financial advisor for Versarien plc.お知らせ • Jul 25Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 846,153,845 Price\Range: £0.00065 Transaction Features: Subsequent Direct Listing最新情報をもっと見るRecent updatesお知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct Listingお知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdomお知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct Listingお知らせ • Dec 10Versarien plc Announces the Launch of New BiosensorsVersarien Plc announced the launch of a new biosensor chip utilising novel graphene barristor sensor platform technology. These graphene barristor devices, developed in South Korea by A Barristor Company ("ABC"), will utilise chemical vapour deposition ("CVD") grown graphene, that is produced under a Versarien licence. Versarien has signed a distribution agreement with ABC to distribute the products in the UK and Europe. A barristor (triode device) is a new type of graphene-based transistor with a Schottky barrier between graphene and silicon. The current modulation is amplified more than 10,000 times compared to graphene field-effect transistors ("GFET") enabling the barristor transistors to overcome many GFET limitations. In these new products, the graphene surface is terminated with either pyrenebutanoic acid succinimidyl ester ("PBASE") or a customer preferred linker. PBASE is one of the most frequently used linkers for the surface modification of field-effect transistor (FET) biosensors based on carbon nanotubes and graphene. The products can be supplied as individual chips or on a wafer scale. It is expected that the CVD graphene used in the products will be supplied by MCK Tech Co. Ltd. ("MCK Tech") in South Korea, which is an existing Licensing partner of Versarien, and it will also undertake some of the device fabrication. The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC's product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.お知らせ • Sep 30Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million.Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million on September 30, 2024. The consideration of £0.55 million is payable in cash, in 16 equal quarterly instalments of £0.0034 million, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £0.146 million and had net assets at 30 September 2023 of £0.411 million. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes. Matthew Johnson, Adam Cowl of SP Angel Corporate Finance LLP acted as financial advisor for Versarien plc.お知らせ • Jul 25Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 846,153,845 Price\Range: £0.00065 Transaction Features: Subsequent Direct ListingNew Risk • Jun 07New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.9m free cash flow). Share price has been highly volatile over the past 3 months (77% average daily change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (460% increase in shares outstanding). Market cap is less than US$10m (€1.42m market cap, or US$1.54m).お知らせ • Mar 29Versarien plc, Annual General Meeting, Apr 30, 2024Versarien plc, Annual General Meeting, Apr 30, 2024, at 09:30 Coordinated Universal Time. Location: Riverbank House, 2 Swan Lane London United KingdomReported Earnings • Mar 28Full year 2023 earnings released: UK£0.055 loss per share (vs UK£0.027 loss in FY 2022)Full year 2023 results: UK£0.055 loss per share (further deteriorated from UK£0.027 loss in FY 2022). Revenue: UK£5.45m (down 26% from FY 2022). Net loss: UK£13.5m (loss widened 156% from FY 2022).お知らせ • Mar 21Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 492,000,000 Price\Range: £0.00125 Transaction Features: Subsequent Direct Listingお知らせ • Jan 19Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: £0.0008 Transaction Features: Subsequent Direct ListingNew Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (93% average daily change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (156% increase in shares outstanding). Market cap is less than US$10m (€1.27m market cap, or US$1.40m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end).お知らせ • Nov 09Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 165,389,817 Price\Range: £0.00275 Transaction Features: Subsequent Direct Listingお知らせ • Jul 21+ 1 more updateVersarien plc Announces Resignation of Neill Ricketts from the BoardVersarien plc received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the company.New Risk • Jul 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 70% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.9m free cash flow). Share price has been highly volatile over the past 3 months (86% average daily change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (70% increase in shares outstanding). Market cap is less than US$10m (€5.13m market cap, or US$5.76m).Reported Earnings • Jun 10First half 2023 earnings released: UK£0.015 loss per share (vs UK£0.011 loss in 1H 2022)First half 2023 results: UK£0.015 loss per share (further deteriorated from UK£0.011 loss in 1H 2022). Revenue: UK£2.62m (down 33% from 1H 2022). Net loss: UK£3.20m (loss widened 55% from 1H 2022).お知らせ • May 19Versarien plc Provides an Update on the Trials of Versarien's Water-Based Graphene Admixture, CementeneTM in Precast Concrete Mixs That Have Been Carried Out by Banagher Precast Concrete LimitedVersarien plc provided an update on the trials of Versarien's water-based graphene admixture, CementeneTM in precast concrete mixes that have been carried out by Banagher Precast Concrete Limited ("Banagher"), a precast concrete manufacturer and supplier of precast concrete products to the civil engineering and construction industries throughout the UK and Ireland. The Company reported that preliminary results from the work undertaken by Banagher have demonstrated that 20% of ordinary Portland cement ("OPC") can be removed from Banagher's typical precast concrete mix when CementeneTM is added, whilst maintaining the compression strength of the concrete. These initial results demonstrate the significant potential to reduce CO2 emissions without impacting the performance of the concrete. The production of 1 kg of CementeneTM is estimated to generate approximately 1.44 kg of CO2 emissions and approximately 5 kg of Cementene TM is used per cubic metre of concrete. The production of 1 km of OPC emits approximately 0.8 kg of CO2 and c.500 kg of OPC is used per cubic metre of Banagher's precast concrete. Therefore, the removal of 20% of OPC in the precast concrete mix (approximately 100 kg) equates to a net saving of approximately 72.8 kg of CO2 emissions per cubic metre of concrete poured. Based on Banagher's average 60,000 cubic metre output of concrete per year, the savings achieved in these trials mean that the incorporation of CementeneTM could offer almost 4.4 million kg of CO2 savings per year at a cost the Company believes is competitive for this level of emissions reduction.Reported Earnings • Feb 26Full year 2022 earnings released: UK£0.028 loss per share (vs UK£0.035 loss in FY 2021)Full year 2022 results: UK£0.028 loss per share (improved from UK£0.035 loss in FY 2021). Revenue: UK£7.40m (down 3.6% from FY 2021). Net loss: UK£5.29m (loss narrowed 19% from FY 2021). Revenue is forecast to stay flat during the next 3 years compared to a 1.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.お知らせ • Dec 07Versarien plc has completed a Follow-on Equity Offering in the amount of £1.85 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £1.85 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 18,500,000 Price\Range: £0.1 Transaction Features: Subsequent Direct ListingBoard Change • Nov 21No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Aug 25Versarien plc, Annual General Meeting, Sep 30, 2022Versarien plc, Annual General Meeting, Sep 30, 2022, at 09:00 Coordinated Universal Time. Location: Gloucester Rugby, Kingsholm Stadium Kingsholm Road, Kingsholm, Gloucester, GL1 3AX Gloucester, United Kingdomお知らせ • Jun 28Versarien plc Announces Launch of New Superparamagnetic MaterialVersarien plc announced the launch of a new hybrid nanomaterial that has superparamagnetic properties, which can be used across a range of applications, such as in defence and healthcare. The development of the material has been led by Versarien's 62% owned subsidiary, Gnanomat S.L. (Gnanomat), whose research has pioneered the generation of a new family of versatile nanocomposites based on graphene and other forms of carbon, combined with metal or metal oxide nanoparticles typically intended for energy storage applications. The superparamagnetic material combines graphene with both iron oxide and manganese oxide nanoparticles that provide the material with magnetic properties. In return, graphene provides electrical conductivity to these electrically insulating metal oxides. Magnetic nanocomposites can readily respond to external magnetic fields which allow them to be manipulated. Potential applications of the material include the treatment of wastewater whereby pollutants are adsorbed onto the graphene surface. The material also lends itself to biomedical and biotechnology applications, or defence applications requiring the shielding of electromagnetic fields. Magnetic manipulation could allow the recovery and recycling of the graphene, something that could not be done with normal graphene compounds.Reported Earnings • May 13Full year 2022 earnings released: UK£0.026 loss per share (vs UK£0.045 loss in FY 2021)Full year 2022 results: UK£0.026 loss per share (up from UK£0.045 loss in FY 2021). Revenue: UK£7.63m (up 16% from FY 2021). Net loss: UK£4.94m (loss narrowed 37% from FY 2021). Over the next year, revenue is expected to shrink by 21% compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.お知らせ • May 03Versarien plc to Report Fiscal Year 2022 Results on May 12, 2022Versarien plc announced that they will report fiscal year 2022 results on May 12, 2022Board Change • Apr 29No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Feb 22Flux Footwear to Launch Graphene Enhanced ShoeVersarien announced that, following a collaboration with Flux Footwear LLC ("Flux"), the Company will be supplying graphene enhanced elastomers to Flux to bring an improved model of Flux's 'Adapt' shoe, the 'AdaptMid', to market. Under the terms of the partnership, the 'Adapt' barefoot athleisure model has been enhanced with Versarien's Graphene-Wear™ technology, following research and testing to improve the rubber outsole, augmenting the shoe's mechanical and physical properties. The new model, the 'AdaptMid', provides greater durability through improved abrasion resistance whilst maintaining the shoe's traction characteristics. This technology has been developed by the Company's in-house technology teams at University of Manchester and University of Cambridge as part of the GSCALE project and has the potential for multiple elastomer projects.Reported Earnings • Dec 08First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: UK£0.015 loss per share (up from UK£0.024 loss in 1H 2021). Revenue: UK£3.82m (up 41% from 1H 2021). Net loss: UK£2.87m (loss narrowed 31% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 39% per year whereas the company’s share price has fallen by 40% per year.Reported Earnings • Aug 06Full year 2021 earnings released: UK£0.044 loss per share (vs UK£0.027 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: UK£6.57m (down 21% from FY 2020). Net loss: UK£7.78m (loss widened 88% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.お知らせ • Feb 09Versarien plc Provides Update on Recent Developments with Regard to the company's Graphene Enhanced Face MasksVersarien plc provided an update on recent developments with regard to the company's graphene enhanced face masks. As reported in the company's interim results announced on 21 January 2021, the Company's wholly owned Chinese subsidiary, Beijing Versarien Technology Company Limited, has been working with its partner on further developments of the masks. This included the testing of a prototype second generation graphene enhanced face mask conducted in China at the Analytical and Testing Centre of Capital Regions which showed a 99.92% anti-viral activity rate against the SARS-CoV-2 virus. In a further development, the Company reported that, after testing of prototypes of the latest version of the mask, which is a non-valve mask, it has been certified as meeting the FFP3 standard, the highest standard under the European EN149 standard for filtering half face masks. The FFP3 certification process, included, inter alia, the testing of the packaging, the robustness of the material, its practical performance, total inward leakage, breathing resistance, clogging, compatibility with skin and the carbon dioxide content of the inhalation air. In order to meet the criteria to be certified as a FFP3 mask, the mask had to pass all the relevant tests, including demonstrating less than 2% inward leakage and the filtering of at least 99% of particulate matter. The testing, to the European EN149 standard, has been carried out in China by SGS-CSTC Standards Technical Services Co. Ltd. a joint venture founded in 1991 between SGS Group, a world leading inspection, verification, testing and certification company, and China Standard Science and Technology Group.Recent Insider Transactions • Jan 23CEO & Executive Director recently sold €1.0m worth of stockOn the 21st of January, Neill Ricketts sold around 2m shares on-market at roughly €0.61 per share. This was the largest sale by an insider in the last 3 months. This was Neill's only on-market trade for the last 12 months.Reported Earnings • Jan 23First half 2021 earnings released: UK£0.025 loss per shareThe company reported a poor first half result with increased losses and weaker revenues and control over expenses. First half 2021 results: Revenue: UK£3.12m (down 29% from 1H 2020). Net loss: UK£4.16m (loss widened 121% from 1H 2020).お知らせ • Jan 08Versarien plc Appoints Stephen Hodge as Chief Technology OfficerVersarien plc announced that Dr. Stephen Hodge has been appointed as the Company's Chief Technology Officer (CTO) and has joined the Company's Board with immediate effect. Dr. Hodge is currently Head of Research at Versarien, a role he has held since July 2018. Prior to this, he was employed as a Principal Engineer at Cambridge Graphene Limited, a supplier of graphene inks and other graphene materials, and a subsidiary of Versarien. He has also held post-doctoral research associate positions at the Cambridge Graphene Centre, a research centre attached to the Department of Engineering at the University of Cambridge, and in the Department of Chemistry at Imperial College London, where he also completed a PhD in Nanomaterial Chemistry. Following Dr. Hodge's appointment, the Company's Board now comprises James Stewart (Non-executive Chairman), Neill Ricketts (CEO), Christopher Leigh (CFO), Stephen Hodge (CTO), Susan Bowen (Non-executive Director) and Iain Gray (Non-executive Director).Is New 90 Day High Low • Jan 05New 90-day high: €0.52The company is up 28% from its price of €0.41 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.Is New 90 Day High Low • Oct 16New 90-day low: €0.34The company is down 18% from its price of €0.42 on 17 July 2020. The German market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.Reported Earnings • Sep 25Full year earnings released - €0.027 loss per shareOver the last 12 months the company has reported total losses of UK£4.15m, with losses widening by 67% from the prior year. Total revenue was UK£8.28m over the last 12 months, down 9.4% from the prior year.Is New 90 Day High Low • Sep 25New 90-day low: €0.37The company is down 21% from its price of €0.47 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.お知らせ • Jul 18Versarien plc to Report Fiscal Year 2020 Results on Aug 11, 2020Versarien plc announced that they will report fiscal year 2020 results on Aug 11, 2020株主還元9RVDE ChemicalsDE 市場7D0%-3.5%2.0%1Y0%1.9%-0.1%株主還元を見る業界別リターン: 9RV過去 1 年間で1.9 % の収益を上げたGerman Chemicals業界を上回りました。リターン対市場: 9RVは、過去 1 年間で-0.1 % のリターンを上げたGerman市場を下回りました。価格変動Is 9RV's price volatile compared to industry and market?9RV volatility9RV Average Weekly Movementn/aChemicals Industry Average Movement6.1%Market Average Movement6.2%10% most volatile stocks in DE Market13.3%10% least volatile stocks in DE Market2.7%安定した株価: 9RVの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間の9RVのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト201064Steve Hodgewww.versarien.comバーサリエン社は、イギリス、ヨーロッパ、北米、そして国際的に様々な産業分野にエンジニアリング・ソリューションを提供している。同社はテクノロジー事業と成熟事業の2つのセグメントで事業を展開している。数層グラフェン「Nanene」、グラフェン強化ポリマー「Polygrene」、数層六方晶窒化ホウ素ナノプレートレット粉末「Hexotene」、エネルギー貯蔵デバイス用グラフェン系ナノ材料のほか、「Graphinks」の名称で、さまざまな印刷プロセス、基板、用途向けの導電性グラフェンインクを提供している。同社は、グラフェン強化プラスチック製品（グラフェン強化モバイルアクセサリー、射出成形製品、工具箱、輸送用トレイ、PU発泡タンク、真空成形製品など）を提供している。また、特殊インサートやブランク、カッティングナイフ、耐摩耗部品、流量制御用ノズルやバルブインサート、防衛・航空宇宙用タングステンカーバイド部品からなる焼結タングステンカーバイド製品も提供している。バーサリエン社は2010年に設立され、英国ロングホープに本社を置いている。もっと見るVersarien plc 基礎のまとめVersarien の収益と売上を時価総額と比較するとどうか。9RV 基礎統計学時価総額€693.54k収益（TTM）-€4.21m売上高(TTM)€1.61m0.4xP/Sレシオ-0.2xPER（株価収益率9RV は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計9RV 損益計算書（TTM）収益UK£1.39m売上原価UK£890.00k売上総利益UK£503.00kその他の費用UK£4.15m収益-UK£3.65m直近の収益報告Mar 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.00061グロス・マージン36.11%純利益率-262.02%有利子負債／自己資本比率-273.6%9RV の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/01/30 05:42終値2025/12/01 00:00収益2025/03/31年間収益2024/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Versarien plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Lydia KennyBerenberg
お知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct Listing
お知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdom
お知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 10Versarien plc Announces the Launch of New BiosensorsVersarien Plc announced the launch of a new biosensor chip utilising novel graphene barristor sensor platform technology. These graphene barristor devices, developed in South Korea by A Barristor Company ("ABC"), will utilise chemical vapour deposition ("CVD") grown graphene, that is produced under a Versarien licence. Versarien has signed a distribution agreement with ABC to distribute the products in the UK and Europe. A barristor (triode device) is a new type of graphene-based transistor with a Schottky barrier between graphene and silicon. The current modulation is amplified more than 10,000 times compared to graphene field-effect transistors ("GFET") enabling the barristor transistors to overcome many GFET limitations. In these new products, the graphene surface is terminated with either pyrenebutanoic acid succinimidyl ester ("PBASE") or a customer preferred linker. PBASE is one of the most frequently used linkers for the surface modification of field-effect transistor (FET) biosensors based on carbon nanotubes and graphene. The products can be supplied as individual chips or on a wafer scale. It is expected that the CVD graphene used in the products will be supplied by MCK Tech Co. Ltd. ("MCK Tech") in South Korea, which is an existing Licensing partner of Versarien, and it will also undertake some of the device fabrication. The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC's product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.
お知らせ • Sep 30Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million.Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million on September 30, 2024. The consideration of £0.55 million is payable in cash, in 16 equal quarterly instalments of £0.0034 million, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £0.146 million and had net assets at 30 September 2023 of £0.411 million. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes. Matthew Johnson, Adam Cowl of SP Angel Corporate Finance LLP acted as financial advisor for Versarien plc.
お知らせ • Jul 25Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 846,153,845 Price\Range: £0.00065 Transaction Features: Subsequent Direct Listing
お知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct Listing
お知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdom
お知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 10Versarien plc Announces the Launch of New BiosensorsVersarien Plc announced the launch of a new biosensor chip utilising novel graphene barristor sensor platform technology. These graphene barristor devices, developed in South Korea by A Barristor Company ("ABC"), will utilise chemical vapour deposition ("CVD") grown graphene, that is produced under a Versarien licence. Versarien has signed a distribution agreement with ABC to distribute the products in the UK and Europe. A barristor (triode device) is a new type of graphene-based transistor with a Schottky barrier between graphene and silicon. The current modulation is amplified more than 10,000 times compared to graphene field-effect transistors ("GFET") enabling the barristor transistors to overcome many GFET limitations. In these new products, the graphene surface is terminated with either pyrenebutanoic acid succinimidyl ester ("PBASE") or a customer preferred linker. PBASE is one of the most frequently used linkers for the surface modification of field-effect transistor (FET) biosensors based on carbon nanotubes and graphene. The products can be supplied as individual chips or on a wafer scale. It is expected that the CVD graphene used in the products will be supplied by MCK Tech Co. Ltd. ("MCK Tech") in South Korea, which is an existing Licensing partner of Versarien, and it will also undertake some of the device fabrication. The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC's product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.
お知らせ • Sep 30Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million.Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million on September 30, 2024. The consideration of £0.55 million is payable in cash, in 16 equal quarterly instalments of £0.0034 million, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £0.146 million and had net assets at 30 September 2023 of £0.411 million. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes. Matthew Johnson, Adam Cowl of SP Angel Corporate Finance LLP acted as financial advisor for Versarien plc.
お知らせ • Jul 25Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 846,153,845 Price\Range: £0.00065 Transaction Features: Subsequent Direct Listing
New Risk • Jun 07New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.9m free cash flow). Share price has been highly volatile over the past 3 months (77% average daily change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (460% increase in shares outstanding). Market cap is less than US$10m (€1.42m market cap, or US$1.54m).
お知らせ • Mar 29Versarien plc, Annual General Meeting, Apr 30, 2024Versarien plc, Annual General Meeting, Apr 30, 2024, at 09:30 Coordinated Universal Time. Location: Riverbank House, 2 Swan Lane London United Kingdom
Reported Earnings • Mar 28Full year 2023 earnings released: UK£0.055 loss per share (vs UK£0.027 loss in FY 2022)Full year 2023 results: UK£0.055 loss per share (further deteriorated from UK£0.027 loss in FY 2022). Revenue: UK£5.45m (down 26% from FY 2022). Net loss: UK£13.5m (loss widened 156% from FY 2022).
お知らせ • Mar 21Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 492,000,000 Price\Range: £0.00125 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 19Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: £0.0008 Transaction Features: Subsequent Direct Listing
New Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (93% average daily change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (156% increase in shares outstanding). Market cap is less than US$10m (€1.27m market cap, or US$1.40m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end).
お知らせ • Nov 09Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 165,389,817 Price\Range: £0.00275 Transaction Features: Subsequent Direct Listing
お知らせ • Jul 21+ 1 more updateVersarien plc Announces Resignation of Neill Ricketts from the BoardVersarien plc received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the company.
New Risk • Jul 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 70% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.9m free cash flow). Share price has been highly volatile over the past 3 months (86% average daily change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (70% increase in shares outstanding). Market cap is less than US$10m (€5.13m market cap, or US$5.76m).
Reported Earnings • Jun 10First half 2023 earnings released: UK£0.015 loss per share (vs UK£0.011 loss in 1H 2022)First half 2023 results: UK£0.015 loss per share (further deteriorated from UK£0.011 loss in 1H 2022). Revenue: UK£2.62m (down 33% from 1H 2022). Net loss: UK£3.20m (loss widened 55% from 1H 2022).
お知らせ • May 19Versarien plc Provides an Update on the Trials of Versarien's Water-Based Graphene Admixture, CementeneTM in Precast Concrete Mixs That Have Been Carried Out by Banagher Precast Concrete LimitedVersarien plc provided an update on the trials of Versarien's water-based graphene admixture, CementeneTM in precast concrete mixes that have been carried out by Banagher Precast Concrete Limited ("Banagher"), a precast concrete manufacturer and supplier of precast concrete products to the civil engineering and construction industries throughout the UK and Ireland. The Company reported that preliminary results from the work undertaken by Banagher have demonstrated that 20% of ordinary Portland cement ("OPC") can be removed from Banagher's typical precast concrete mix when CementeneTM is added, whilst maintaining the compression strength of the concrete. These initial results demonstrate the significant potential to reduce CO2 emissions without impacting the performance of the concrete. The production of 1 kg of CementeneTM is estimated to generate approximately 1.44 kg of CO2 emissions and approximately 5 kg of Cementene TM is used per cubic metre of concrete. The production of 1 km of OPC emits approximately 0.8 kg of CO2 and c.500 kg of OPC is used per cubic metre of Banagher's precast concrete. Therefore, the removal of 20% of OPC in the precast concrete mix (approximately 100 kg) equates to a net saving of approximately 72.8 kg of CO2 emissions per cubic metre of concrete poured. Based on Banagher's average 60,000 cubic metre output of concrete per year, the savings achieved in these trials mean that the incorporation of CementeneTM could offer almost 4.4 million kg of CO2 savings per year at a cost the Company believes is competitive for this level of emissions reduction.
Reported Earnings • Feb 26Full year 2022 earnings released: UK£0.028 loss per share (vs UK£0.035 loss in FY 2021)Full year 2022 results: UK£0.028 loss per share (improved from UK£0.035 loss in FY 2021). Revenue: UK£7.40m (down 3.6% from FY 2021). Net loss: UK£5.29m (loss narrowed 19% from FY 2021). Revenue is forecast to stay flat during the next 3 years compared to a 1.7% growth forecast for the Chemicals industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
お知らせ • Dec 07Versarien plc has completed a Follow-on Equity Offering in the amount of £1.85 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £1.85 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 18,500,000 Price\Range: £0.1 Transaction Features: Subsequent Direct Listing
Board Change • Nov 21No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Aug 25Versarien plc, Annual General Meeting, Sep 30, 2022Versarien plc, Annual General Meeting, Sep 30, 2022, at 09:00 Coordinated Universal Time. Location: Gloucester Rugby, Kingsholm Stadium Kingsholm Road, Kingsholm, Gloucester, GL1 3AX Gloucester, United Kingdom
お知らせ • Jun 28Versarien plc Announces Launch of New Superparamagnetic MaterialVersarien plc announced the launch of a new hybrid nanomaterial that has superparamagnetic properties, which can be used across a range of applications, such as in defence and healthcare. The development of the material has been led by Versarien's 62% owned subsidiary, Gnanomat S.L. (Gnanomat), whose research has pioneered the generation of a new family of versatile nanocomposites based on graphene and other forms of carbon, combined with metal or metal oxide nanoparticles typically intended for energy storage applications. The superparamagnetic material combines graphene with both iron oxide and manganese oxide nanoparticles that provide the material with magnetic properties. In return, graphene provides electrical conductivity to these electrically insulating metal oxides. Magnetic nanocomposites can readily respond to external magnetic fields which allow them to be manipulated. Potential applications of the material include the treatment of wastewater whereby pollutants are adsorbed onto the graphene surface. The material also lends itself to biomedical and biotechnology applications, or defence applications requiring the shielding of electromagnetic fields. Magnetic manipulation could allow the recovery and recycling of the graphene, something that could not be done with normal graphene compounds.
Reported Earnings • May 13Full year 2022 earnings released: UK£0.026 loss per share (vs UK£0.045 loss in FY 2021)Full year 2022 results: UK£0.026 loss per share (up from UK£0.045 loss in FY 2021). Revenue: UK£7.63m (up 16% from FY 2021). Net loss: UK£4.94m (loss narrowed 37% from FY 2021). Over the next year, revenue is expected to shrink by 21% compared to a 6.4% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
お知らせ • May 03Versarien plc to Report Fiscal Year 2022 Results on May 12, 2022Versarien plc announced that they will report fiscal year 2022 results on May 12, 2022
Board Change • Apr 29No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Feb 22Flux Footwear to Launch Graphene Enhanced ShoeVersarien announced that, following a collaboration with Flux Footwear LLC ("Flux"), the Company will be supplying graphene enhanced elastomers to Flux to bring an improved model of Flux's 'Adapt' shoe, the 'AdaptMid', to market. Under the terms of the partnership, the 'Adapt' barefoot athleisure model has been enhanced with Versarien's Graphene-Wear™ technology, following research and testing to improve the rubber outsole, augmenting the shoe's mechanical and physical properties. The new model, the 'AdaptMid', provides greater durability through improved abrasion resistance whilst maintaining the shoe's traction characteristics. This technology has been developed by the Company's in-house technology teams at University of Manchester and University of Cambridge as part of the GSCALE project and has the potential for multiple elastomer projects.
Reported Earnings • Dec 08First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: UK£0.015 loss per share (up from UK£0.024 loss in 1H 2021). Revenue: UK£3.82m (up 41% from 1H 2021). Net loss: UK£2.87m (loss narrowed 31% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 39% per year whereas the company’s share price has fallen by 40% per year.
Reported Earnings • Aug 06Full year 2021 earnings released: UK£0.044 loss per share (vs UK£0.027 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: UK£6.57m (down 21% from FY 2020). Net loss: UK£7.78m (loss widened 88% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 33% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 09Versarien plc Provides Update on Recent Developments with Regard to the company's Graphene Enhanced Face MasksVersarien plc provided an update on recent developments with regard to the company's graphene enhanced face masks. As reported in the company's interim results announced on 21 January 2021, the Company's wholly owned Chinese subsidiary, Beijing Versarien Technology Company Limited, has been working with its partner on further developments of the masks. This included the testing of a prototype second generation graphene enhanced face mask conducted in China at the Analytical and Testing Centre of Capital Regions which showed a 99.92% anti-viral activity rate against the SARS-CoV-2 virus. In a further development, the Company reported that, after testing of prototypes of the latest version of the mask, which is a non-valve mask, it has been certified as meeting the FFP3 standard, the highest standard under the European EN149 standard for filtering half face masks. The FFP3 certification process, included, inter alia, the testing of the packaging, the robustness of the material, its practical performance, total inward leakage, breathing resistance, clogging, compatibility with skin and the carbon dioxide content of the inhalation air. In order to meet the criteria to be certified as a FFP3 mask, the mask had to pass all the relevant tests, including demonstrating less than 2% inward leakage and the filtering of at least 99% of particulate matter. The testing, to the European EN149 standard, has been carried out in China by SGS-CSTC Standards Technical Services Co. Ltd. a joint venture founded in 1991 between SGS Group, a world leading inspection, verification, testing and certification company, and China Standard Science and Technology Group.
Recent Insider Transactions • Jan 23CEO & Executive Director recently sold €1.0m worth of stockOn the 21st of January, Neill Ricketts sold around 2m shares on-market at roughly €0.61 per share. This was the largest sale by an insider in the last 3 months. This was Neill's only on-market trade for the last 12 months.
Reported Earnings • Jan 23First half 2021 earnings released: UK£0.025 loss per shareThe company reported a poor first half result with increased losses and weaker revenues and control over expenses. First half 2021 results: Revenue: UK£3.12m (down 29% from 1H 2020). Net loss: UK£4.16m (loss widened 121% from 1H 2020).
お知らせ • Jan 08Versarien plc Appoints Stephen Hodge as Chief Technology OfficerVersarien plc announced that Dr. Stephen Hodge has been appointed as the Company's Chief Technology Officer (CTO) and has joined the Company's Board with immediate effect. Dr. Hodge is currently Head of Research at Versarien, a role he has held since July 2018. Prior to this, he was employed as a Principal Engineer at Cambridge Graphene Limited, a supplier of graphene inks and other graphene materials, and a subsidiary of Versarien. He has also held post-doctoral research associate positions at the Cambridge Graphene Centre, a research centre attached to the Department of Engineering at the University of Cambridge, and in the Department of Chemistry at Imperial College London, where he also completed a PhD in Nanomaterial Chemistry. Following Dr. Hodge's appointment, the Company's Board now comprises James Stewart (Non-executive Chairman), Neill Ricketts (CEO), Christopher Leigh (CFO), Stephen Hodge (CTO), Susan Bowen (Non-executive Director) and Iain Gray (Non-executive Director).
Is New 90 Day High Low • Jan 05New 90-day high: €0.52The company is up 28% from its price of €0.41 on 07 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period.
Is New 90 Day High Low • Oct 16New 90-day low: €0.34The company is down 18% from its price of €0.42 on 17 July 2020. The German market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 5.0% over the same period.
Reported Earnings • Sep 25Full year earnings released - €0.027 loss per shareOver the last 12 months the company has reported total losses of UK£4.15m, with losses widening by 67% from the prior year. Total revenue was UK£8.28m over the last 12 months, down 9.4% from the prior year.
Is New 90 Day High Low • Sep 25New 90-day low: €0.37The company is down 21% from its price of €0.47 on 26 June 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period.
お知らせ • Jul 18Versarien plc to Report Fiscal Year 2020 Results on Aug 11, 2020Versarien plc announced that they will report fiscal year 2020 results on Aug 11, 2020
